WRRisk Description
The product assigns a risk score to each patient. This allows for a digital personalized screening plan that provides more consistent follow-up recommendations, and a more accurate diagnosis. This helps to detect cancers in women at highest risk. WRRisk is a digital breast cancer risk assessment that combines digital forms from patients with a density assessment to create a single risk scorecard. WRRisk automates many manual steps such as collecting forms and generating letters. This reduces the complexity of breast risk program maintenance. The product provides information for patients and providers. WRRisk calculates 10-year and lifetime risks, as well as risk-based upon runner-up density.
WRRisk Alternatives
WRDensity
WRDensity aids radiologists in interpreting breast densities to ensure uniform density assessments at the practice level. Its goal is to aid in early detection1 and give patients peace of mind through consistency, confidence, quality, and care. WRDensity was trained with deep learning based upon over 600,000 images taken by Mallinckrodt Institute of Radiology. This is one of the most respected radiology research institutes in the world. WRDensity's powerful deep-learning model is able to accurately classify breast density. The batching and sorting feature of WRDensity can increase productivity by up to 20% for users. WRDensity can be accessed within the existing workstation of radiologist, making relevant information about tissue density available in context.
Learn more
Volpara Health
Volpara Health software is used by facilities to detect breast cancer early, including at top US cancer screening centers. Volpara Health software is used by mammography technologists to improve the quality of mammograms. The most scientifically-validated screening software in breast health. Volpara provides the evidence you need, when you need it. Access to patient data allows for a more informed assessment of breast cancer risk. Every image we analyze improves our algorithms to detect breast cancer early. Your advocacy for additional screening and genetic testing of patients. You can create worklists and reports according to your preferences. You can simultaneously access stats and lists on one screen. Standardize communications between patients, referrers, insurers, and other parties. Use mammogram thumbnails to send more compelling results letters.
Learn more
Mesh Bio
DARA is based on medical science and explainable system biology and enables and enhances clinical intervention guidance and decision support. We collaborate with healthcare providers and stakeholders to offer digital solutions that transform chronic disease management and health screening. Through clinical workflow automation and predictive analysis, we enable digital transformation in care delivery. Our solutions are based on best practices and gold standard clinical guidelines. We enable physicians to better engage with patients by providing actionable health insight through personalized disease risk and adverse events predictions. We help pharmaceutical development by uncovering pharmacodynamics within complex biological processes and finding novel therapeutic interventions. Predictive analytics based on multidimensional patient data will allow personalized precision medicine to manage cardiometabolic diseases and prevent catastrophic patient outcomes.
Learn more
Artrya
Artrya partners up with chest pain clinics to provide new models of cardiology care that are based on AI. Easy integration of plaque features with high prognostic values into the evaluation for coronary artery disease. Quick assessment of patients suffering from chest pain in primary and emergency care. We envision a world in which communities are not plagued by high rates of heart attacks. AI-driven insights into the volume and type of arterial plaque detected by coronary computed tomography angiography, (CCTA), allow for the rapid stratification of patients suffering from chest pain. With the confidence that there are no plaque features, you can quickly determine if a patient has minimal to zero coronary disease. Early warning signs of a possible heart attack are easily detected. You can effectively rule out patients at high risk for severe or atypical chest discomfort that warrants further investigation and therapy.
Learn more
Integrations
No Integrations at this time
Company Details
Company:
Whiterabbit.ai
Year Founded:
2017
Headquarters:
United States
Website:
www.whiterabbit.ai/products/wrrisk
Media
Recommended Products
Build enterprise-ready GenAI experiences with MongoDB Atlas
MongoDB Atlas is a unified developer platform that enables you to confidently accelerate the deployment of GenAI-powered applications. Additionally, when purchased on Google Cloud Marketplace, you pay for only the resources you use with no upfront commitment.
Product Details
Platforms
SaaS
Type of Training
Documentation
Live Online
Customer Support
Online
WRRisk Features and Options
WRRisk Lists
WRRisk User Reviews
Write a Review- Previous
- Next